Doctor Care Anywhere posted an 8.4% quarterly jump in consultations and sustained positive cashflow for the fourth consecutive quarter, while launching new digital health initiatives and reaffirming its medium-term revenue and profitability targets.
- Consultations rose 8.4% quarter-on-quarter and 2.0% year-on-year
- Fourth consecutive quarter of positive net operating and investing cash inflow (£0.6m)
- Cash position strengthened to £7.0m, supporting growth investments
- New digital exercise and skin cancer pathways launched with encouraging early outcomes
- Medium-term guidance reaffirmed: revenue doubling over 3–5 years, 15% EBITDA margin target
Consultation Growth Surges Amid Digital Expansion
Doctor Care Anywhere (ASX:DOC) delivered a notable 8.4% increase in consultation volumes quarter-on-quarter for Q1 2026, alongside a 2.0% lift compared to the prior corresponding period. This acceleration was underpinned by the onboarding of Mental Health Practitioners and Physiotherapists, as well as enhancements to the booking process that cut patient wait times. Activated Lives, the total users signed up, rose 6.4% year-on-year to 1.3 million, reflecting steady platform engagement. Repeat patients accounted for 75% of consultations, consistent with prior quarters but up three percentage points annually, signaling growing patient retention.
These gains build on the momentum seen in previous quarters, including the steady consultation increases reported in H2 2025. The company’s strategic push into new clinical pathways is also bearing fruit, with the digital exercise programme for physiotherapy and a skin cancer pathway now fully launched. Early feedback indicates these offerings are delivering tangible value to patients and clients alike, with the skin cancer pathway achieving a discharge rate exceeding 60% and delivering results within two days. Doctor Care Anywhere is also piloting health assessments internally, with plans for external rollout in the second half of 2026.
Sustained Cashflow Strength Bolsters Growth Prospects
Financially, Doctor Care Anywhere maintained its positive cashflow trajectory, reporting a net operating and investing cash inflow of £0.6 million (A$1.2 million) for Q1 2026. This marks the fourth consecutive quarter of positive cash generation, a stark contrast to the £1.6 million cash outflow in the same quarter last year. The company ended the period with a robust cash balance of £7.0 million (A$13.5 million), up from £2.8 million a year earlier, providing a solid foundation for ongoing investment in growth and product development.
The quarter-on-quarter dip in receipts from customers (down 5.5%) was attributed to timing factors, while increases in non-operating staff costs reflect new hires and consultant engagements. Meanwhile, other administrative costs declined due to the smoothing of annual insurance payments and supplier settlements. These operational efficiencies align with the company’s broader focus on converting earlier cost-cutting measures into sustainable profitability and growth momentum.
Medium-Term Targets Remain Ambitious
Doctor Care Anywhere reaffirmed its medium-term guidance, aiming to double revenues to £76 million (A$156 million) within 3 to 5 years, implying a compound annual growth rate exceeding 12%. The company also targets an EBITDA margin of 15%, a significant step up from current levels. These targets are contingent on various assumptions and risks, including market conditions and execution of growth initiatives.
This reaffirmation follows the company’s first profitable year reported earlier in 2026, where it posted an underlying EBITDA margin of nearly 14% and a net profit of £1.2 million, setting a precedent for the current growth phase. The sustained positive cashflow and operational improvements suggest that Doctor Care Anywhere is steadily progressing towards these goals, supported by its expanding digital health offerings and enhanced patient experience.
Notably, the company carries £10.6 million in zero-coupon convertible debt maturing in December 2027, which remains a key balance sheet consideration as it balances growth investments with financial discipline.
Product Innovation and Operational Efficiency Drive Differentiation
Beyond consultation volumes, Doctor Care Anywhere is actively refining its operating model. The prescription fulfilment journey with its strategic pharmacy partner has launched, enhancing patient choice and convenience. Internal pilots of health assessments and AI-driven tools such as ambient scribes and patient verification are underway, aiming to boost internal efficiency and patient engagement.
The company is also exploring extensions of its skin cancer pathway into broader dermatology services and is developing a new user journey for direct-to-consumer customers, offering clinician availability upfront to streamline bookings. These initiatives are part of a broader strategy to diversify and deepen the customer base while improving clinical outcomes.
These developments echo the company’s recent progress, including its first profit and sustained consultation growth, as detailed in its first profitable year report. The consistent execution of digital health pilots and operational enhancements suggests a deliberate effort to cement its position in the competitive UK telehealth market.
Bottom Line?
Doctor Care Anywhere’s steady consultation growth and sustained cashflow provide a solid runway, but the challenge remains to convert digital innovations into scalable, profitable revenue streams amid evolving market dynamics.
Questions in the middle?
- How will the company manage the £10.6 million convertible debt maturing in late 2027 amid growth investments?
- What impact will the rollout of health assessments and expanded dermatology services have on consultation volumes and margins?
- Can Doctor Care Anywhere maintain its positive cashflow momentum if customer receipts fluctuate due to timing or market factors?